BSX · trading date Oct 12, 2026 · previous close $42.74 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$20.07B
Net income
$2.90B
Total assets
$43.67B
Total liabilities
—
Stockholders' equity
$24.23B
Cash & equivalents
$1.97B
Operating income
$3.61B
Operating cash flow
$4.53B
Capital expenditures
$876.00M
Fiscal year 2025, via 10-K filed 2026-02-17.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
18.0%
Net margin
14.4%
Free cash flow
$3.66B
Free cash flow margin
18.2%
Liabilities / assets
—
Equity / assets
55.5%
CapEx / revenue
4.4%
Operating cash flow / net income
1.56×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Marlborough, MA 01752-1234
300 BOSTON SCIENTIFIC WAY
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.